Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization M. A. QadirB. KwokSharon M. Gorski Preclinical Study 03 January 2008 Pages: 389 - 403
Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis Satoshi NakayamaYasuo MiyoshiShinzaburo Noguchi Preclinical Study 28 December 2007 Pages: 405 - 410
Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study Shuhua LvYun NiuYan Chen Preclinical Study 13 January 2008 Pages: 411 - 418
Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer M. IhnenV. MüllerK. Milde-Langosch Preclinical Study 03 January 2008 Pages: 419 - 427
Characterisation of aromatase expression in the human adipocyte cell line SGBS Kerry J. McInnesKristy A. BrownEvan R. Simpson Preclinical Study 05 January 2008 Pages: 429 - 435
Disruption of ERα signalling pathway by PPARγ agonists: evidences of PPARγ-independent events in two hormone-dependent breast cancer cell lines Julie LecomteStéphane FlamentIsabelle Grillier-Vuissoz Preclinical Study 20 January 2008 Pages: 437 - 451
New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up K. C. JensenD. A. TurbinR. B. West Preclinical Study 09 January 2008 Pages: 453 - 459
Comparison of magnetic resonance imaging, multidetector row computed tomography, ultrasonography, and mammography for tumor extension of breast cancer Takayoshi UematsuSachiko YuenYoshihiro Uchida Preclinical Study 12 January 2008 Pages: 461 - 474
Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance Djuana M. E. HarvellNicole S. SpoelstraJennifer K. Richer Preclinical Study 09 March 2008 Pages: 475 - 488
Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor Djuana M. E. HarvellJennifer K. RicherKathryn B. Horwitz Preclinical Study 13 March 2008 Pages: 489 - 501
Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases Michael BraunUta FluckeWalther Kuhn Clinical Trial 29 December 2007 Pages: 503 - 511
Paget’s disease of the breast: the experience of the European institute of oncology and review of the literature Mujgan CaliskanGiovanna GattiAlberto Luini Clinical Trial 01 February 2008 Pages: 513 - 521
The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population M. KlarA. JochmannD. Watermann Clinical Trial 03 January 2008 Pages: 523 - 531
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses David CameronMichelle CaseyCharles E. Geyer Clinical Trial 11 January 2008 Pages: 533 - 543
Oncological results of immediate breast reconstruction: long term follow-up of a large series at a single institution J. Y. PetitO. GentiliniA. Luini Clinical Trial 22 January 2008 Pages: 545 - 549
HER2 in well differentiated breast cancer: is testing necessary? G. Kenneth Haines IIIElizabeth WileyFattaneh A. Tavassoli Clinical Trial 18 January 2008 Pages: 551 - 556
Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG) Zsuzsanna KahánStanislav SpanikThomas Brodowicz Clinical Trial 13 January 2008 Pages: 557 - 563
Is face-only photographic view enough for the aesthetic evaluation of breast cancer conservative treatment? Maria João CardosoAndré MagalhãesJaime S. Cardoso Clinical Trial 18 January 2008 Pages: 565 - 568
The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation Doo Ho ChoiDae Yeon ChoBruce G. Haffty Epidemiology 03 January 2008 Pages: 569 - 573
Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus Maria A. LoizidouThalia MichaelAndreas Hadjisavvas Epidemiology 10 January 2008 Pages: 575 - 579
Early radiation exposures and BRCA1-associated breast cancer in young women from Poland Jacek GronwaldAnouk PijpeSteven A. Narod Epidemiology 18 January 2008 Pages: 581 - 584
Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer Joanne KotsopoulosWilliam W. ZhangSteven A. Narod Epidemiology 19 January 2008 Pages: 585 - 593
Decline in breast cancer incidence in the United States: what about male breast cancer? Andreas StangChristoph Thomssen Letter to the Editor 05 January 2008 Pages: 595 - 596
